About: Resistance to docetaxel in prostate cancer is associated with androgen receptor activation and loss of KDM5D expression

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Resistance to docetaxel in prostate cancer is associated with androgen receptor activation and loss of KDM5D expression Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific journal article

Attributes	Values
rdf:type	Item
description	2016年學術文章 (zh) artículu científicu espublizáu en 2016 (ast) vědecký článek publikovaný v roce 2016 (cs) 2016 թուականի Մայիսին հրատարակուած գիտական յօդուած (hyw) наукова стаття, опублікована в травні 2016 (uk) 2016 թվականի մայիսին հրատարակված գիտական հոդված (hy) vedecký článok (publikovaný 2016/05/31) (sk) مقالة علمية (نشرت في 31-5-2016) (ar) wetenschappelijk artikel (gepubliceerd op 2016/05/31) (nl) im Mai 2016 veröffentlichter wissenschaftlicher Artikel (de) article publié dans les Proceedings of the National Academy of Sciences of the United States of America (fr) scientific journal article (en)
publication date	wds:Q28117805-2FF8912F-2C23-494F-9881-E7139A8F86B8
publication date	2016-05-16 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q28117805-18273BCC-E99C-4A1C-A793-C26D90364564
language of work or name	English
cites work	wds:Q28117805-0337E743-3569-44D6-AAED-22E7C3426D3D wds:Q28117805-061CA58B-9207-42B9-BB4F-6472CEE152B1 wds:Q28117805-107D0847-1813-4049-81DC-2D72A5CA93D2 wds:Q28117805-1AE22D83-5F89-4409-913D-7CCA7031B06E wds:Q28117805-249BE24D-3B03-465A-B9ED-A063723FDAEC wds:Q28117805-26299323-0AD1-4A23-B1AB-DEE1688F3CEA wds:Q28117805-332ED4C4-FFFD-43A8-90EA-FCAB46D03008 wds:Q28117805-3E9C9F88-C131-4A48-A14C-6E4D245D6BF4 wds:Q28117805-43658971-EB25-465E-B7B3-FB2983490294 wds:Q28117805-4AC1718E-9F5A-4EAD-9B0C-07DF4200AC14 wds:Q28117805-504A3109-F822-4F67-8327-6F8FE9275D5F wds:Q28117805-555EAFA5-8F13-4161-8ED1-7BAFB07878B2 wds:Q28117805-6254133C-7FF6-42AF-A20B-5B9C42F9DB38 wds:Q28117805-6A38A510-6F4D-4A80-8B68-64ADD5FEBD44 wds:Q28117805-703A80C2-43E0-4B12-9DE8-711BEA4A00B0 wds:Q28117805-73FCE8EB-EFE8-4284-A132-18F1C5ACD544 wds:Q28117805-76518C56-29B7-4939-9C49-0FFCCE84DE76 wds:Q28117805-7A57ADB6-5243-4536-8A16-FBD4FC02B0F3 wds:Q28117805-85BA3606-58C6-43B4-857D-62E4709C99D4 wds:Q28117805-901D3B67-C98A-4B0A-BC5E-F13465531E0C wds:Q28117805-9C0F742A-45D2-449A-A995-C131C3FB0049 wds:Q28117805-A0EA9672-DE72-4163-9001-5FBB38441976 wds:Q28117805-AB11E676-B5F6-44C5-961E-1178085B5463 wds:Q28117805-BBC448A4-40CC-4D41-A044-DD4863629BA6 wds:Q28117805-C21F4A0A-FE46-4D94-B12B-F597686D3941 wds:Q28117805-C38DFEF8-4794-49D8-85CB-DB71F1E58CE0 wds:Q28117805-CE46B63D-7297-4738-A395-A02130BB652D wds:Q28117805-E362DB6D-6D50-48DF-98CD-0D3B3F09F2DF wds:Q28117805-E648C44E-97A4-4049-9431-6629FDFF0DE7 wds:Q28117805-EC9ECFA3-0E64-485E-BA4A-05C835E65921 wds:Q28117805-F02E9E87-F5DB-4568-B71B-7BFC73D129A8
cites work	An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression The mutational landscape of lethal castration-resistant prostate cancer Physical and functional association of a trimethyl H3K4 demethylase and Ring6a/MBLR, a polycomb-like protein Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Integrative molecular concept modeling of prostate cancer progression. Transcriptional silencing of zinc finger protein 185 identified by expression profiling is associated with prostate cancer progression Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease Integrative genomic profiling of human prostate cancer The X-linked mental retardation gene SMCX/JARID1C defines a family of histone H3 lysine 4 demethylases JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer Comparative pharmacokinetics of weekly and every-three-weeks docetaxel. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer Integrative clinical genomics of advanced prostate cancer Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer Neoadjuvant docetaxel before radical prostatectomy in patients with high-risk localized prostate cancer Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance Androgen receptor splice variants determine taxane sensitivity in prostate cancer Novel actions of next-generation taxanes benefit advanced stages of prostate cancer JARID1D Is a Suppressor and Prognostic Marker of Prostate Cancer Invasion and Metastasis. ERG induces taxane resistance in castration-resistant prostate cancer MDC1 functionally identified as an androgen receptor co-activator participates in suppression of prostate cancer. Timing is everything: preclinical evidence supporting simultaneous rather than sequential chemohormonal therapy for prostate cancer
author name string	wds:Q28117805-1D7D2F93-DC4C-479D-99A8-20ECF88EDDDD wds:Q28117805-2B1FD796-0D0D-4520-9B79-2ED00C3ED4B2 wds:Q28117805-49849002-3836-4CC6-AC44-51BCD184B302 wds:Q28117805-4AEE6BEC-1228-4455-9383-26E18F9CA7ED
OpenCitations bibliographic resource ID	wds:Q28117805-91AA50F6-2E60-4EE8-8859-9995FF7154DA
OpenCitations bibliographic resource ID	https://w3id.org/oc/corpus/br/4218459
author name string	Xiaodong Wang Seong Ho Jeong Masayuki Hiraki Fangfang Qu
OpenCitations bibliographic resource ID	4218459
rdfs:label	Resistance to docetaxel in prostate cancer is associated with androgen receptor activation and loss of KDM5D expression (en) Resistance to docetaxel in prostate cancer is associated with androgen receptor activation and loss of KDM5D expression (nl) Resistance to docetaxel in prostate cancer is associated with androgen receptor activation and loss of KDM5D expression (ast)
skos:prefLabel	Resistance to docetaxel in prostate cancer is associated with androgen receptor activation and loss of KDM5D expression (en) Resistance to docetaxel in prostate cancer is associated with androgen receptor activation and loss of KDM5D expression (nl) Resistance to docetaxel in prostate cancer is associated with androgen receptor activation and loss of KDM5D expression (ast)
name	Resistance to docetaxel in prostate cancer is associated with androgen receptor activation and loss of KDM5D expression (en) Resistance to docetaxel in prostate cancer is associated with androgen receptor activation and loss of KDM5D expression (nl) Resistance to docetaxel in prostate cancer is associated with androgen receptor activation and loss of KDM5D expression (ast)
author	wds:Q28117805-168C5F5C-6498-48A6-AC61-B235C5FB7843

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software